VIVEbiotech is also collaborating with a range of different suppliers to make its operations as efficient as possible.

Following a fresh round of job cuts in December, CDMO National Resilience is carrying its downsizing efforts into 2025. | ...

Solid Biosciences Inc. SLDB announced that the FDA has cleared its investigational new drug (IND) application to begin ...

UC San Diego Health one of a few health care systems on West Coast to offer new gene therapy for hemophilia B.

UC Davis Health has premiered a new documentary on a family’s urgent journey across the globe to get their toddler in a clinical trial for patients with Duchenne Muscular Dystrophy, or DMD.

A study published in Human Gene Therapy has involved the generation of a human monoclonal antibody (mAb) directed against ...

National Resilience acquired the Triangle office in 2021. Since then, funding for gene therapy solutions has fallen.

Researchers at the Experimental and Clinical Research Center (ECRC), a joint institution of the Max Delbrück Center and ...

The three-year partnership is another example of Vertex’s interest in improving on Casgevy, its CRISPR medicine for sickle ...

WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing ...

Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies ...